Drugs Health Pharma

India caps trade margins on 42 anti-cancer medicines

India has put a cap on the trade margin of 42 selected non-scheduled anti-cancer medicines, including ribociclib, which is used to treat breast.

Read More
Drugs Medical Pharma

Yemen, Lebanon allege India’s Celon Labs’ drug ‘substandard’

The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories,.

Read More
Drugs Medical Pharma

Ransomware group behind cyberattack: Sun Pharma

A ransomware group has breached the information security network of India's Sun Pharmaceuticals unit, and there is a possibility that "file systems, business and personal.

Read More
Health Pharma

World Bank loans India $1 billion to aid healthcare sector

The Indian government and the World Bank signed two agreements to support and enhance the development of the health sector in the south.

Read More
Medical Pharma

Wipro unveils ‘tamper-proof’ self-verifiable digital wallet

India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to.

Read More
Drugs Pharma

Global Pharma recalls eye drops after FDA contamination warning

India-based Global Pharma Healthcare voluntarily recalled all lots of its artificial tears lubricant eye drops after the USFDA reported possible contamination.

Read More
Drugs Medical Pharma

Max Healthcare profit jumps 7%, to raise INR 42 billion in debt

Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,.

Read More
Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near term’

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Read More
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More
Drugs Pharma

India’s pharma market to be worth $130 billion by 2030

The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic.

Read More